Biotech Startups

Isabl develops whole genome and transcriptome sequencing technology for cancer diagnosis, delivering comprehensive genomic profiling and treatment options to physicians and research teams. The company provides rapid cancer diagnostic tests in clinically relevant timeframes to improve outcomes for cancer patients globally.

1 investor

Isabl develops genomic sequencing technology for cancer diagnosis, enabling whole genome and transcriptome testing in clinically relevant timeframes to provide comprehensive treatment options. The platform serves physicians and cancer patients globally by making advanced molecular diagnostics accessible.

1 investor

The Institute for Systems Biology (ISB) is a research organization focused on systems biology science and education, including curriculum development, educator engagement, and student research programs.

1 investor

Isolation Bio develops technology and services for accelerated microbial research and discovery. The company offers the Prospector platform for high-throughput microbial screening and cultivation, alongside custom microbial isolation and cultivation services for researchers.

1 investor

Isomab develops first-in-class antibody therapies targeting specific VEGF-A isoforms to restore blood vessel growth and improve blood flow in cardiovascular diseases. The company was spun out of the University of Nottingham in 2022 and builds on over 20 years of vascular biology research.

1 investor

Isospec Analytics provides glycome and metabolome analysis for biomarker discovery, combining liquid chromatography-mass spectrometry with proprietary CIRIS technology and AI to identify molecular signatures beyond current library limitations.

1 investor

1 investor

1 investor

ITM is a vertically integrated biotechnology company specializing in precision oncology through radioisotope production and radiopharmaceutical development, with clinical programs advanced through subsidiary Lumara Bio. The company manufactures and supplies medical radioisotopes including Lutetium-177 and Actinium-225 for cancer detection and treatment.

1 investor

iuvo is a contract research organization (CRO) focused exclusively on ophthalmology, managing clinical trials across anterior and posterior eye segments from protocol development through regulatory submission. It serves sponsors and innovators developing eye care drugs and ocular devices, running trials across North America and internationally.

1 investor

1 investor

iXpressGenes operates a CLIA-certified, CAP-accredited molecular diagnostics laboratory that provides genetic testing and analysis services.

1 investor

Izon Science develops nanoparticle separation and analysis instruments for biological research and nanomedicine development, including platforms for isolating extracellular vesicles and measuring physical characteristics of nano-sized particles. The company serves researchers and therapeutic developers globally with solutions ranging from individual instruments to automated, cGMP-compliant systems for industrial-scale processing.

1 investor

Greater Winston-Salem Inc. is an economic development organization for Winston-Salem/Forsyth County, North Carolina, offering business development, advocacy, networking, talent recruitment, and marketing services. It also provides memberships and career resources to attract and support companies and job seekers in the region.

1 investor

Javelin Biotech develops microphysiological systems and organ-on-chip platforms combined with digital twin software to predict drug efficacy in humans for the biopharmaceutical industry. The company offers tissue chip-based preclinical models that accelerate drug discovery by replacing traditional animal studies.

1 investor

Jazz Venture Partners is a venture capital firm whose portfolio spans companies working on human performance, health, and technology across digital therapeutics, biosciences, AI, and neuroscience. The page is a portfolio listing rather than a page for an operating company.

1 investor

JCCT is a clinical research organization that conducts hundreds of trials for biotech firms, pharmaceutical companies, and public health organizations. The company operates state-of-the-art facilities and provides comprehensive research services including participant recruitment, study management, and data management.

1 investor

Jenthera is a CRISPR therapeutics company developing gene-editing treatments based on scientific research and industry expertise.

1 investor

Jeonjin Biopharm (전진바이오팜) develops products based on natural materials, including detergents, deodorizers/air fresheners, capsule detergents (laundry and dishwasher), and animal damage-reduction agents, and offers OEM/ODM manufacturing. The South Korean company also conducts R&D in natural-material applications.

1 investor

JITSUBO develops Molecular Hiving™, a peptide synthesis technology, and provides contract manufacturing of active pharmaceutical ingredients (APIs) and technology licensing. The company serves the pharmaceutical industry from its base in Yokohama, Japan.

1 investor

J-Land Biotech is a biotech company specializing in the industrialization and application of recombinant proteins, particularly collagen, leveraging bioengineering techniques in gene recombination, microbial fermentation, and protein purification. The company serves manufacturers, medical institutions, and end users across pharmaceuticals, medical aesthetics, cosmetics, biomimetic materials, and food sectors globally.

1 investor

Jointechlabs develops point-of-care regenerative medicine devices, including the FDA-cleared MiniTC for processing autologous fat into microfat and the CE-marked Mini-Stem System for SVF processing. Its products are used by doctors and clinics for applications such as pain management, orthopedics, sports medicine, aesthetics, reconstruction, and wound healing.

1 investor

Jooules produces alternative protein using microbes and gaseous fermentation to address sustainability challenges in the food sector. The company serves food producers and processors seeking efficient, bioscience-based protein production methods.

1 investor

1 investor